Pharma sector under DGGI Scanner; about ₹450 crore of GST dues recovered in FY24

In another drive to curb GST leakages across several sectors, the Directorate General of GST Intelligence (DGGI) is understood to have registered 41 cases against pharma majors across the country in FY24, sources told CNBC-TV18. DGGI  claims that pharma companies have evaded GST primarily on account of "brand transfer sales, claiming fake ITC on expired drugs, taking fake ITC for busines…